Table 5.
Emotional well being | Role limitation emotional | Health distress | Cognitive function | Overall quality of life | ||||||
Effect | β | p | β | p | β | p | β | p | β | p |
Intercept* | 73.6 | <.0001 | 53.68 | <.0001 | 69.6 | <.0001 | 78.3 | <.0001 | 68.6 | <.0001 |
Age at inclusion | -0.31 | 0.32 | -0.11 | 0.45 | 0.08 | 0.57 | -0.41 | 0.01 | 0.02 | 0.86 |
Gender (Male vs. Female) | -19.83 | 0.003 | 1.68 | 0.57 | -3.69 | 0.19 | -8.55 | 0.01 | -4.05 | 0.14 |
Disease duration | -0.29 | 0.49 | 0.13 | 0.50 | 0.08 | 0.69 | -0.16 | 0.49 | 0.13 | 0.49 |
Disease course (SP vs. RR) | 15.2 | 0.15 | 8.75 | 0.08 | 4.21 | 0.37 | 14.8 | 0.008 | -2.55 | 0.57 |
Relapse rate 2-yrs before study entry | -0.31 | 0.97 | 0.15 | 0.96 | -0.31 | 0.92 | -0.40 | 0.92 | -1.40 | 0.66 |
EDSS | 1.15 | 0.71 | -2.13 | 0.14 | -0.11 | 0.93 | -0.70 | 0.67 | -1.51 | 0.25 |
BDI | -1.50 | <.0007 | -1.86 | <.0001 | -1.75 | <.0001 | -1.01 | <.0001 | -1.35 | <.0001 |
FSS | -8.33 | <.0005 | 1.67 | 0.12 | -2.86 | 0.005 | -1.06 | 0.38 | 0.02 | 0.98 |
MMSE-c | 0.15 | 0.91 | 0.42 | 0.44 | 0.84 | 0.11 | 1.69 | 0.009 | 0.39 | 0.46 |
IFN-β treatment (Yes vs No) | 7.67 | 0.34 | 5.22 | 0.13 | 4.99 | 0.13 | 3.12 | 0.44 | -1.16 | 0.73 |
Relapse rate change after 2-yrs | -4.36 | 0.57 | 3.64 | 0.39 | -1.90 | 0.72 | 2.90 | 0.51 | -3.34 | 0.35 |
EDSS change after 2-yrs | 2.95 | 0.44 | -1.32 | 0.54 | 1.57 | 0.56 | 3.09 | 0.17 | -0.24 | 0.89 |
BDI change after 2-yrs | -1.65 | <.0001 | -1.20 | <.0001 | -0.84 | 0.003 | -0.91 | .0001 | -1.15 | <.0001 |
FSS change after 2-yrs | -3.63 | 0.13 | -1.14 | 0.38 | -3.66 | 0.02 | -0.20 | 0.88 | -2.65 | 0.02 |
MMSE-c change after 2-yrs | -1.29 | 0.42 | 0.58 | 0.50 | 1.42 | 0.20 | 0.04 | 0.97 | -1.40 | 0.6 |
Time** | 5.68 | 0.37 | 5.31 | 0.11 | 4.15 | 0.32 | -0.64 | 0.86 | 0.31 | 0.91 |
Time × IFN-β treatment (Yes vs no) | -19.11 | 0.03 | -4.95 | 0.27 | -12.29 | 0.03 | -9.65 | 0.05 | 2.53 | 0.54 |
*Intercept value represents the baseline mean score for reference group (Untreated)
**Time value represents the mean score change for reference group (Untreated) after 2 years of follow-up